Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


Combinatorial detection of autoreactive CD8+ T cells with HLA-A2 multimers: a multi-centre study by the Immunology of Diabetes Society T Cell Workshop.

James EA, Abreu JRF, McGinty JW, Odegard JM, FilliƩ YE, Hocter CN, Culina S, Ladell K, Price DA, Alkanani A, Rihanek M, Fitzgerald-Miller L, Skowera A, Speake C, Gottlieb P, Davidson HW, Wong FS, Roep B, Mallone R; Immunology of Diabetes Society T Cell Workshop Committee.

Diabetologia. 2018 Mar;61(3):658-670. doi: 10.1007/s00125-017-4508-8. Epub 2017 Dec 1.


Longitudinal monitoring of gene expression in ultra-low-volume blood samples self-collected at home.

Speake C, Whalen E, Gersuk VH, Chaussabel D, Odegard JM, Greenbaum CJ.

Clin Exp Immunol. 2017 May;188(2):226-233. doi: 10.1111/cei.12916. Epub 2017 Mar 2.


NETosis-associated serum biomarkers are reduced in type 1 diabetes in association with neutrophil count.

Qin J, Fu S, Speake C, Greenbaum CJ, Odegard JM.

Clin Exp Immunol. 2016 Jun;184(3):318-22. doi: 10.1111/cei.12783. Epub 2016 Apr 13.


A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs.

Odegard JM, Flynn PA, Campbell DJ, Robbins SH, Dong L, Wang K, Ter Meulen J, Cohen JI, Koelle DM.

Vaccine. 2016 Jan 2;34(1):101-9. doi: 10.1016/j.vaccine.2015.10.137. Epub 2015 Nov 10.


Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation.

Speake C, Odegard JM.

Biomark Insights. 2015 Sep 29;10(Suppl 4):19-24. doi: 10.4137/BMI.S29697. eCollection 2015. Review.


Biomarkers for antigen immunotherapy in allergy and type 1 diabetes.

Odegard JM, Nepom GT, Wambre E.

Clin Immunol. 2015 Nov;161(1):44-50. doi: 10.1016/j.clim.2015.05.023. Epub 2015 Jun 27. Review.


Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy.

Odegard JM, Kelley-Clarke B, Tareen SU, Campbell DJ, Flynn PA, Nicolai CJ, Slough MM, Vin CD, McGowan PJ, Nelson LT, Ter Meulen J, Dubensky TW Jr, Robbins SH.

J Immunother. 2015 Feb-Mar;38(2):41-53. doi: 10.1097/CJI.0000000000000067.


Low HERV-K(C4) copy number is associated with type 1 diabetes.

Mason MJ, Speake C, Gersuk VH, Nguyen QA, O'Brien KK, Odegard JM, Buckner JH, Greenbaum CJ, Chaussabel D, Nepom GT.

Diabetes. 2014 May;63(5):1789-95. doi: 10.2337/db13-1382. Epub 2014 Jan 15.


Design of a novel integration-deficient lentivector technology that incorporates genetic and posttranslational elements to target human dendritic cells.

Tareen SU, Kelley-Clarke B, Nicolai CJ, Cassiano LA, Nelson LT, Slough MM, Vin CD, Odegard JM, Sloan DD, Van Hoeven N, Allen JM, Dubensky TW Jr, Robbins SH.

Mol Ther. 2014 Mar;22(3):575-587. doi: 10.1038/mt.2013.278. Epub 2013 Dec 6.


A Rev-Independent gag/pol Eliminates Detectable psi-gag Recombination in Lentiviral Vectors.

Tareen SU, Nicolai CJ, Campbell DJ, Flynn PA, Slough MM, Vin CD, Kelley-Clarke B, Odegard JM, Robbins SH.

Biores Open Access. 2013 Dec 1;2(6):421-30. doi: 10.1089/biores.2013.0037.


In vivo regulation of Bcl6 and T follicular helper cell development.

Poholek AC, Hansen K, Hernandez SG, Eto D, Chandele A, Weinstein JS, Dong X, Odegard JM, Kaech SM, Dent AL, Crotty S, Craft J.

J Immunol. 2010 Jul 1;185(1):313-26. doi: 10.4049/jimmunol.0904023. Epub 2010 Jun 2.


Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation.

Marks BR, Nowyhed HN, Choi JY, Poholek AC, Odegard JM, Flavell RA, Craft J.

Nat Immunol. 2009 Oct;10(10):1125-32. doi: 10.1038/ni.1783. Epub 2009 Sep 6. Erratum in: Nat Immunol. 2010 Jan;11(1):97.


ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus.

Odegard JM, DiPlacido LD, Greenwald L, Kashgarian M, Kono DH, Dong C, Flavell RA, Craft J.

J Immunol. 2009 Apr 1;182(7):4076-84. doi: 10.4049/jimmunol.0800758.


ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity.

Odegard JM, Marks BR, DiPlacido LD, Poholek AC, Kono DH, Dong C, Flavell RA, Craft J.

J Exp Med. 2008 Nov 24;205(12):2873-86. doi: 10.1084/jem.20080840. Epub 2008 Nov 3.


Intrinsic T cell defects in systemic autoimmunity.

Kong PL, Odegard JM, Bouzahzah F, Choi JY, Eardley LD, Zielinski CE, Craft JE.

Ann N Y Acad Sci. 2003 Apr;987:60-7. Review.


Supplemental Content

Loading ...
Support Center